Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Argus Research Maintains Buy on UnitedHealth Group, Raises Price Target to $600

Author: Benzinga Newsdesk | July 17, 2024 01:42pm
Argus Research analyst David Toung maintains UnitedHealth Group (NYSE:UNH) with a Buy and raises the price target from $570 to $600.

Posted In: UNH

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist